Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
102M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
94.1M
-
Shares change
-
+184K
-
Total reported value, excl. options
-
$746M
-
Value change
-
-$40.5M
-
Put/Call ratio
-
1.5
-
Number of buys
-
108
-
Number of sells
-
-67
-
Price
-
$7.93
Significant Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q1 2025
217 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - COMMON STOCK as of Q1 2025.
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.1M shares
of 102M outstanding shares and own 92.22% of the company stock.
Largest 10 shareholders include FMR LLC (13.7M shares), BlackRock, Inc. (6.76M shares), Atlas Venture Life Science Advisors, LLC (6.43M shares), VANGUARD GROUP INC (5.94M shares), RA CAPITAL MANAGEMENT, L.P. (5.76M shares), Alyeska Investment Group, L.P. (4.06M shares), FRANKLIN RESOURCES INC (4.02M shares), Pictet Asset Management Holding SA (3.64M shares), BRAIDWELL LP (3.54M shares), and Estuary Capital Management LP (3.33M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.